Verona Pharma PLC (VRNA)
12.04
+0.04
(+0.33%)
USD |
NASDAQ |
May 24, 16:00
12.04
0.00 (0.00%)
After-Hours: 20:00
Verona Pharma Accounts Payable (Quarterly): 4.651M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.651M |
December 31, 2023 | 3.492M |
September 30, 2023 | 0.823M |
June 30, 2023 | 2.493M |
March 31, 2023 | 7.237M |
December 31, 2022 | 2.91M |
September 30, 2022 | 8.002M |
June 30, 2022 | 9.364M |
March 31, 2022 | 8.064M |
December 31, 2021 | 10.04M |
September 30, 2021 | 0.009M |
June 30, 2021 | 0.034M |
March 31, 2021 | 0.541M |
December 31, 2020 | 0.178M |
September 30, 2020 | 14.19M |
June 30, 2020 | 8.753M |
March 31, 2020 | 8.188M |
December 31, 2019 | 1.931M |
September 30, 2019 | 14.26M |
June 30, 2019 | 11.15M |
March 31, 2019 | 6.326M |
December 31, 2018 | 3.602M |
September 30, 2018 | 7.468M |
June 30, 2018 | 7.229M |
March 31, 2018 | 8.081M |
Date | Value |
---|---|
December 31, 2017 | 1.641M |
September 30, 2017 | 6.366M |
June 30, 2017 | 6.906M |
December 31, 2016 | 0.8871M |
June 30, 2016 | 1.688M |
June 30, 2016 | 1.688M |
December 31, 2015 | 1.899M |
June 30, 2015 | 0.8983M |
June 30, 2015 | 0.8983M |
December 31, 2014 | 0.5706M |
June 30, 2014 | 0.6904M |
June 30, 2014 | 0.6904M |
December 31, 2013 | 0.5438M |
June 30, 2013 | 0.2653M |
June 30, 2013 | 0.2653M |
December 31, 2012 | 0.2192M |
June 30, 2012 | 0.1571M |
June 30, 2012 | 0.1571M |
December 31, 2011 | 0.1382M |
June 30, 2011 | 0.4597M |
December 31, 2010 | 0.2192M |
June 30, 2010 | 0.0978M |
December 31, 2009 | 0.1892M |
June 30, 2009 | 0.0938M |
December 31, 2008 | 0.0718M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.009M
Minimum
Sep 2021
14.26M
Maximum
Sep 2019
5.816M
Average
5.944M
Median
Accounts Payable (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | 0.40M |
NuCana PLC | 7.277M |
Bicycle Therapeutics PLC | 7.061M |
TC BioPharm (Holdings) PLC | 2.434M |
Adaptimmune Therapeutics PLC | 6.587M |